Showing 19,481 - 19,500 results of 28,618 for search '(( significant decrease decrease ) OR ( significant ((degrees decrease) OR (gene increased)) ))', query time: 0.66s Refine Results
  1. 19481

    Image 1_Spatial metabolomics and transcriptomics reveal cell type-specific dynamics in the placenta of patients with late-onset preeclampsia.jpeg by Xiaowei Wei (516076)

    Published 2025
    “…A “spot-match” method was developed to integrate ST and SM data, revealing cell type-specific gene and metabolite changes during trophoblast differentiation.…”
  2. 19482

    Image 5_Species and genetic diversity of nontuberculous mycobacteria in suspected tuberculosis cases in East Azerbaijan, Iran: a cross-sectional analysis.png by Mehdi Roshdi Maleki (19938024)

    Published 2024
    “…Introduction<p>The incidence of nontuberculous mycobacterial (NTM) infections has increased worldwide, attracting attention in routine diagnostic settings, particularly among patients with suspected tuberculosis. …”
  3. 19483

    Fas2 interacting partner IgCAMs Fipi and Elff are required for imaginal disc development. by Luis Garcia-Alonso (152388)

    Published 2024
    “…While the fas2 RNAi produces a strong decrease in MAPK activation with respect to the control siblings (see also [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0309891#pone.0309891.ref008" target="_blank">8</a>]), the combined expression of fipi and elff RNAis produces a significant increase.…”
  4. 19484

    Image 1_Construction of a stromal cell-related prognostic signature based on a 101-combination machine learning framework for predicting prognosis and immunotherapy response in tri... by Fanrong Li (21356156)

    Published 2025
    “…</p>Results<p>In TNBC, three stromal cell subpopulations—myofibroblastic cancer-associated fibroblasts (myCAF), vascular smooth muscle cells (VSMCs), and pericytes—were enriched, exhibiting high interaction frequencies and strong associations with poor prognosis. A nine-gene prognostic model (MVPRS), developed from 23 prognostically significant genes among the 259 MVPRGs, demonstrated excellent predictive performance and was validated as an independent prognostic factor. …”
  5. 19485

    Table 5_DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications.xlsx by RenCai Lu (22702223)

    Published 2025
    “…Drug sensitivity analysis revealed that high DDR1 expression was associated with reduced sensitivity to methotrexate but increased sensitivity to vinblastine, doxorubicin, cisplatin, and docetaxel, with no significant difference observed for gefitinib. …”
  6. 19486

    Table 1_Construction of a stromal cell-related prognostic signature based on a 101-combination machine learning framework for predicting prognosis and immunotherapy response in tri... by Fanrong Li (21356156)

    Published 2025
    “…</p>Results<p>In TNBC, three stromal cell subpopulations—myofibroblastic cancer-associated fibroblasts (myCAF), vascular smooth muscle cells (VSMCs), and pericytes—were enriched, exhibiting high interaction frequencies and strong associations with poor prognosis. A nine-gene prognostic model (MVPRS), developed from 23 prognostically significant genes among the 259 MVPRGs, demonstrated excellent predictive performance and was validated as an independent prognostic factor. …”
  7. 19487

    Table 1_DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications.xlsx by RenCai Lu (22702223)

    Published 2025
    “…Drug sensitivity analysis revealed that high DDR1 expression was associated with reduced sensitivity to methotrexate but increased sensitivity to vinblastine, doxorubicin, cisplatin, and docetaxel, with no significant difference observed for gefitinib. …”
  8. 19488

    Table 3_DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications.xlsx by RenCai Lu (22702223)

    Published 2025
    “…Drug sensitivity analysis revealed that high DDR1 expression was associated with reduced sensitivity to methotrexate but increased sensitivity to vinblastine, doxorubicin, cisplatin, and docetaxel, with no significant difference observed for gefitinib. …”
  9. 19489

    Table 4_DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications.xlsx by RenCai Lu (22702223)

    Published 2025
    “…Drug sensitivity analysis revealed that high DDR1 expression was associated with reduced sensitivity to methotrexate but increased sensitivity to vinblastine, doxorubicin, cisplatin, and docetaxel, with no significant difference observed for gefitinib. …”
  10. 19490

    Data Sheet 1_DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications.pdf by RenCai Lu (22702223)

    Published 2025
    “…Drug sensitivity analysis revealed that high DDR1 expression was associated with reduced sensitivity to methotrexate but increased sensitivity to vinblastine, doxorubicin, cisplatin, and docetaxel, with no significant difference observed for gefitinib. …”
  11. 19491

    Table 6_DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications.xlsx by RenCai Lu (22702223)

    Published 2025
    “…Drug sensitivity analysis revealed that high DDR1 expression was associated with reduced sensitivity to methotrexate but increased sensitivity to vinblastine, doxorubicin, cisplatin, and docetaxel, with no significant difference observed for gefitinib. …”
  12. 19492

    Table 2_DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications.xlsx by RenCai Lu (22702223)

    Published 2025
    “…Drug sensitivity analysis revealed that high DDR1 expression was associated with reduced sensitivity to methotrexate but increased sensitivity to vinblastine, doxorubicin, cisplatin, and docetaxel, with no significant difference observed for gefitinib. …”
  13. 19493

    Table 7_DDR1 as a key prognostic biomarker in non-small cell lung cancer: identification, validation, and potential therapeutic implications.xlsx by RenCai Lu (22702223)

    Published 2025
    “…Drug sensitivity analysis revealed that high DDR1 expression was associated with reduced sensitivity to methotrexate but increased sensitivity to vinblastine, doxorubicin, cisplatin, and docetaxel, with no significant difference observed for gefitinib. …”
  14. 19494

    Data Sheet 1_Construction of a stromal cell-related prognostic signature based on a 101-combination machine learning framework for predicting prognosis and immunotherapy response i... by Fanrong Li (21356156)

    Published 2025
    “…</p>Results<p>In TNBC, three stromal cell subpopulations—myofibroblastic cancer-associated fibroblasts (myCAF), vascular smooth muscle cells (VSMCs), and pericytes—were enriched, exhibiting high interaction frequencies and strong associations with poor prognosis. A nine-gene prognostic model (MVPRS), developed from 23 prognostically significant genes among the 259 MVPRGs, demonstrated excellent predictive performance and was validated as an independent prognostic factor. …”
  15. 19495

    Table 1_SarZ inhibits the hemolytic activity through regulation of phenol soluble modulins in Staphylococcus epidermidis.docx by Xiao Chen (260187)

    Published 2024
    “…The sarZ psmβ double mutant was further generated and displayed a significantly decreased hemolytic activity compared with the sarZ mutant. …”
  16. 19496

    Image 6_SarZ inhibits the hemolytic activity through regulation of phenol soluble modulins in Staphylococcus epidermidis.jpeg by Xiao Chen (260187)

    Published 2024
    “…The sarZ psmβ double mutant was further generated and displayed a significantly decreased hemolytic activity compared with the sarZ mutant. …”
  17. 19497

    Image 7_SarZ inhibits the hemolytic activity through regulation of phenol soluble modulins in Staphylococcus epidermidis.jpeg by Xiao Chen (260187)

    Published 2024
    “…The sarZ psmβ double mutant was further generated and displayed a significantly decreased hemolytic activity compared with the sarZ mutant. …”
  18. 19498

    Image 10_SarZ inhibits the hemolytic activity through regulation of phenol soluble modulins in Staphylococcus epidermidis.jpeg by Xiao Chen (260187)

    Published 2024
    “…The sarZ psmβ double mutant was further generated and displayed a significantly decreased hemolytic activity compared with the sarZ mutant. …”
  19. 19499

    Image 8_SarZ inhibits the hemolytic activity through regulation of phenol soluble modulins in Staphylococcus epidermidis.jpeg by Xiao Chen (260187)

    Published 2024
    “…The sarZ psmβ double mutant was further generated and displayed a significantly decreased hemolytic activity compared with the sarZ mutant. …”
  20. 19500

    The regulation of AsfR on tmRNA expression mediates bacterial motility and virulence by Huimin Chang (21142907)

    Published 2025
    “…Consistently, the transcription level of tmRNA was significantly decreased in Δ<i>asfR</i> compared with WT of <i>A. veronii </i>by quantitative real-time PCR (RT-qPCR) analyses. …”